DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.
Name reflects vertically-aligned healthcare ecosystem business model integrating data captured via telemedicine, online pharmacy, lab tests and wearables to perfect...
Day: June 26, 2026
Hemostemix Closes $360,000 First Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - June 26, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
Charlotte’s Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access
California takes a pre-2018 Farm Bill approach that restricts access, even as federal momentum builds to protect access to therapeutic...
QScreen AI Announces Adoption of Semi-Annual Reporting
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or...
11 Press Releases You Need to See This Week
Including AbbVie's acquisition of Apogee Therapeutics, new Mountain Dew commemorative cans and Taco Bell's emotional support taco platform.NEW YORK, June...
Dr. Jason M. Cuéllar Performs Inaugural Surgery at DISC Surgery Center at Palm Beach
Milestone Expands Access to Advanced Motion-Preserving and Minimally Invasive Spine Care WEST PALM BEACH, FL / ACCESS Newswire / June...
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
~ ~ Advances First-in-Class, Breakthrough Therapy-Designated Opioid Engineered to Protect Against Oral Overdose ~ ~ SAN DIEGO, CA / ACCESS...
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026...
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
Allschwil, Switzerland – June 26, 2026Idorsia Ltd (SIX: IDIA), a commercial-stage biopharmaceutical company with a portfolio of first- or best-in-class...
MEDIROM MOTHER Labs Expands Deployment of “REMONY®” Remote Health Monitoring System in JGSDF 8th Division
Additional Orders Triple Implementation Scale; "MOTHER Bracelet®" Enables Continuous Safety Monitoring During Extended Training TOKYO, June 25, 2026 (GLOBE NEWSWIRE)...
Canadian Red Cross launches appeal to support people impacted by the earthquakes in Venezuela
OTTAWA, Ontario, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working to support those impacted by the...
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company...
Eikon Therapeutics to Join the Russell 3000® Index
Addition reflects Eikon's progress as a publicly traded company and increasing visibility within the investment communityMILLBRAE, Calif., June 25, 2026...
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
LEXINGTON, Mass. and AMSTERDAM, June 25, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing...
DLH Contract Award Opens New Growth Channels with U.S Navy
ATLANTA, June 25, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its...
Ligand Announces Closing of Convertible Senior Notes Offering
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase...
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the...
Keros Therapeutics Appoints Anne Prener to its Board of Directors
LEXINGTON, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...